patent
Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection
2024
The disclosure provides antibodies, or antigen-binding fragments thereof, and use thereof in prophylaxis, treatment and/or attenuation of a SARS-CoV-2 virus infection.
Type
patent
EPO Family ID
88295860
Author(s)
Note
Alternative title(s) : (fr) Anticorps anti-sars-cov-2 et utilisation associée dans le traitement d'une infection par sars-cov-2
TTO classification
TTO:6.2374
| DOI | Country code | Kind code | Date issued |
WO2024068996 | WO | A1 | 2024-04-04 |
Available on Infoscience
May 6, 2024
Use this identifier to reference this record